Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

21 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

NCT03688074

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Denver, Colorado, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View all 28 locations
View Trial Details
Completed

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

NCT03627767

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • University of Alabama at Birmingham, Dermatology at the Whitaker Clinic Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • Tien Q Nguyen MD Inc dba First OC Dermatology Fountain Valley, California, United States
View all 235 locations
View Trial Details
Completed

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Marvel Research, LLC Huntington Beach, California, United States
  • Alliance Research Centers Laguna Hills, California, United States
View all 216 locations
View Trial Details
Completed

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

NCT03054428

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +16 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Bakersfield, California, United States
  • Regeneron Investigational Site Long Beach, California, United States
View all 45 locations
View Trial Details
Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

NCT01904604

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +3 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • National Jewish Health Denver, Colorado, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details

Related conditions